The 2026 Evidence

The record did not stop with FY2025. Through the first quarter of 2026 — the freshest hard data in the file — net profit rose about 67% to Rp2.58tn on sales up 12.7%, led by day-old chicks (+77.6%) and feed (+28.4%) [1][2]. A ramping government meals programme underpins protein demand. At about 8.9x record FY2025 earnings, the share price still embeds a normalisation of the spread; the evidence printed since runs the other way.

The record extended, it did not roll over

Everything in this report to here has been retrospective — how CPIN earned its FY2025 result and what it was worth — leaving open whether that year was a peak or a durable base. The one place to test it directly is the data that has printed since: the first quarter of 2026 and the demand backdrop behind it.

The recovery kept going. Nine-month 2025 profit was already up 41.2% year on year [3]; the full year closed +52%. Then Q1 2026 net profit reached Rp2.58tn, up from Rp1.54tn a year earlier, on net sales of Rp19.95tn — a 12.7% top-line gain that the company attributes to both higher chicken prices and higher volume [4]. This is not a business reverting toward mid-cycle; it is one printing above the record it just set.

Source: Q1 FY2026 net sales by segment, Note 23 [5]; net-profit figure from company results as reported [6].

The segment mix tells the more useful story. CPIN's Q1 net sales by line make clear the 2026 acceleration is not broad-based — it is concentrated in exactly the parts of the chain that price off the spread the market worries about.

Source: Q1 FY2026 Consolidated Financial Statements, Note 23 Net Sales [7].

Broiler sales — the largest line — grew only 3.7%, and processed chicken was flat. The lift came from day-old chicks, up 77.6%, and feed, up 28.4%. Both are upstream of the finished bird: DOC prices lead the broiler cycle, and feed volume rises when farmers restock. A near-doubling of DOC revenue in one quarter is the clearest read that the sector was still tightening into 2026, not loosening — the same DOC-price strength that was the one downstream line to gain on price in the record year, now amplified. It builds directly on the efficiency-led recovery documented in Downstream Cycle, where FY2025's broiler result rose 64.89% to Rp3.35tn even as the average broiler selling price fell [8].

The demand side has a policy floor

The cyclical read has a structural companion that did not exist in prior troughs. Since 6 January 2025, Indonesia has run Makan Bergizi Gratis (MBG), a national free-nutritious-meals scheme championed by President Prabowo Subianto. It is not a small programme: the government allocated roughly Rp335tn (about US$21bn) to it for the current year, and realised spending reached Rp88.15tn by the end of May 2026 — up from Rp75tn a month earlier — feeding 48.9 million students and 14.3 million other beneficiaries through 29,679 kitchens (figures from Indonesia's Ministry of Finance and National Nutrition Agency; the government programme is not an issuer filing, so it is cited here as reported public data rather than a source PDF).

Chicken is a core protein in that meal plan, and the corpus shows the market has treated MBG as a genuine demand catalyst for poultry since late 2025 — sell-side and local coverage tied CPIN's Q3 2025 sector recovery to "rising broiler prices, tighter supply and MBG budget increase," and by January 2026 Vanguard and BlackRock had raised their stakes with MBG cited among the tailwinds [9]. Management's own framing is consistent: the FY2025 report attributes the farm-segment margin recovery to "more balanced supply-demand conditions and disciplined production planning," which "helped stabilise pricing and improve profitability" [10].

A ramping, budgeted demand programme is a different kind of support from a normal cyclical upswing. It gives the bull's normalised-earnings case — that FY2025 is closer to a new base than a peak — its first piece of forward, non-price evidence.

Three reasons the market is not convinced

The price implies the opposite. At Rp3,070 on 15 July 2026, CPIN trades near the lower end of its cyclical multiple range — about 8.9x its record FY2025 earnings — even as results accelerate, the anticipatory de-rating dissected in Pricing the Cycle. Three facts keep that scepticism honest.

First, MBG's translation into CPIN profit is asserted, not yet demonstrated. The programme has been a stock-narrative catalyst since 2024, and for its first year the narrative outran the numbers: in November 2024, coverage noted CPIN's profit and share price were weak despite the MBG programme (Bisnis.com, cited as public data). MBG procurement is decentralised across tens of thousands of local kitchens and spans eggs, fish and other proteins, not only broiler — how much of the Rp335tn actually flows to CPIN's product lines is nowhere quantified in the filings. The demand floor is real for the sector; CPIN's capture of it is unmeasured.

Second, the strength arrives with capex accelerating into it — the watch item from Cash Conversion. Capex re-accelerated to Rp1.70tn in FY2025 from a Rp0.76tn trough, and through 2025 the company kept expanding aggressively — a poultry breeding facility and a Rp430bn land-and-machinery purchase — even while it held to conservative full-year guidance [11]. Adding capacity at the top of a spread cycle is the classic way integrators convert a good year into the next glut; the timing is a risk precisely because current conditions are good.

Third, the recovery is not a rising tide. In the same FY2025 that CPIN set a record, PT Widodo Makmur Unggas — a smaller, downstream-heavy integrator — booked a net loss of Rp83bn on sales of Rp741bn, citing "weakening purchasing power," higher feed-input costs, and "DOC and livebird price fluctuation" [12]. The favourable 2026 setup rewards scale and integration; it does not lift everyone, which means the "sector recovery" is thinner than the headlines and more dependent on CPIN's own cost position than on a broad demand wave.

What would settle it

The observed data through Q1 2026 favours durability over reversion, but the quarter carries a seasonal Ramadan lift and one strong quarter does not make a base. Three checks over the rest of 2026 would move the read in either direction. Whether broiler selling prices hold through the second half — not the DOC and restocking strength that led Q1, but the finished-bird price that drives the largest segment — is the cleanest test of whether the spread has a floor or is topping. Whether MBG's realised spend keeps climbing toward its Rp335tn allocation, and whether any of it shows up as a broiler or processed-chicken volume line rather than sector sentiment, would convert the demand story from asserted to measured. And whether the FY2025 capacity additions arrive into firm or softening prices will show, within a year or two, whether the capex was well-timed or the seed of the next down-leg. Until those print, the record stands extended, and the discount rests on the assumption that it cannot last.